Agape ATP received notice from Nasdaq on July 19, 2024, indicating its failure to regain compliance with the minimum bid price requirement of $1 per share, following an initial notification on January 18, 2024. The company was given a 180-day compliance period until July 16, 2024, which has now expired.Nasdaq has determined that the company's securities will be delisted and suspended from trading on July 30, 2024, as it does not meet the minimum stockholders' equity requirements for initial listing. However, Agape ATP intends to request a hearing before the Nasdaq Hearings Panel, which will temporarily stay the delisting action.The company plans to present a compliance restoration plan at the hearing, seeking additional time for recovery. While management expresses confidence in presenting a viable plan, there is no guarantee that the Panel will approve the continued listing request.

Agape ATP received notice from Nasdaq on July 19, 2024, indicating its failure to regain compliance with the minimum bid price requirement of $1 per share, following an initial notification on January 18, 2024. The company was given a 180-day compliance period until July 16, 2024, which has now expired.Nasdaq has determined that the company's securities will be delisted and suspended from trading on July 30, 2024, as it does not meet the minimum stockholders' equity requirements for initial listing. However, Agape ATP intends to request a hearing before the Nasdaq Hearings Panel, which will temporarily stay the delisting action.The company plans to present a compliance restoration plan at the hearing, seeking additional time for recovery. While management expresses confidence in presenting a viable plan, there is no guarantee that the Panel will approve the continued listing request.